122 related articles for article (PubMed ID: 15939586)
1. Aromatase and comparative response to its inhibitors in two types of endometrial cancer.
Berstein L; Kovalevskij A; Zimarina T; Maximov S; Gershfeld E; Vasilyev D; Baisheva S; Baymakhasheva A; Thijssen JH
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):71-4. PubMed ID: 15939586
[TBL] [Abstract][Full Text] [Related]
2. CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease.
Berstein L; Zimarina T; Kovalevskij A; Maximov S; Volkov O; Thijssen JH
Neoplasma; 2005; 52(2):115-8. PubMed ID: 15800709
[TBL] [Abstract][Full Text] [Related]
3. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
4. Aromatase expression in stromal cells of endometrioid endometrial cancer correlates with poor survival.
Segawa T; Shozu M; Murakami K; Kasai T; Shinohara K; Nomura K; Ohno S; Inoue M
Clin Cancer Res; 2005 Mar; 11(6):2188-94. PubMed ID: 15788666
[TBL] [Abstract][Full Text] [Related]
5. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies.
Watanabe K; Sasano H; Harada N; Ozaki M; Niikura H; Sato S; Yajima A
Am J Pathol; 1995 Feb; 146(2):491-500. PubMed ID: 7856758
[TBL] [Abstract][Full Text] [Related]
6. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
Soufla G; Sifakis S; Spandidos DA
Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
[TBL] [Abstract][Full Text] [Related]
7. [Tumor tissue aromatase and estrogen levels versus clinical course of endometrial cancer].
Bersteĭn LM; Chernobrovkina AE; Gamaiunova VB; Vasil'ev DA; Kovalevskiĭ AIu; Maksimov SIa; Chepik OF; Gershfel'd ED
Vopr Onkol; 2003; 49(1):55-9. PubMed ID: 12715371
[TBL] [Abstract][Full Text] [Related]
8. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
[TBL] [Abstract][Full Text] [Related]
9. Aromatase in the context of breast and endometrial cancer. A review.
Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
[TBL] [Abstract][Full Text] [Related]
10. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
[TBL] [Abstract][Full Text] [Related]
11. Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction.
Matsumoto M; Yamaguchi Y; Seino Y; Hatakeyama A; Takei H; Niikura H; Ito K; Suzuki T; Sasano H; Yaegashi N; Hayashi S
Endocr Relat Cancer; 2008 Jun; 15(2):451-63. PubMed ID: 18508998
[TBL] [Abstract][Full Text] [Related]
12. [Criteria for evaluating the effectiveness of aromatase inhibitors in the neoadjuvant treatment of patients with endometrial carcinoma].
Bershteĭn LM; Danilova MA; Kovalevskiĭ AIu; Gershfel'd ED; Poroshina TE; Tsyrlina TE; Meshkova IE; Turkevich EA; Maksimov SIa
Vopr Onkol; 2009; 55(3):314-8. PubMed ID: 19670731
[TBL] [Abstract][Full Text] [Related]
13. Endometrial aromatase mRNA as a possible screening tool for advanced endometriosis and adenomyosis.
Hatok J; Zubor P; Galo S; Kirschnerova R; Dobrota D; Danko J; Racay P
Gynecol Endocrinol; 2011 May; 27(5):331-6. PubMed ID: 20553220
[TBL] [Abstract][Full Text] [Related]
14. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis.
Kyama CM; Overbergh L; Mihalyi A; Meuleman C; Mwenda JM; Mathieu C; D'Hooghe TM
Fertil Steril; 2008 Feb; 89(2):301-10. PubMed ID: 17678915
[TBL] [Abstract][Full Text] [Related]
15. Human aromatase: gene resequencing and functional genomics.
Ma CX; Adjei AA; Salavaggione OE; Coronel J; Pelleymounter L; Wang L; Eckloff BW; Schaid D; Wieben ED; Adjei AA; Weinshilboum RM
Cancer Res; 2005 Dec; 65(23):11071-82. PubMed ID: 16322257
[TBL] [Abstract][Full Text] [Related]
16. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
[TBL] [Abstract][Full Text] [Related]
17. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
18. [Aromatase gene expression and its modifying factors in breast tumor tissue].
Berstein LM; Larionov AA; Pauley RJ; Chernitsa OI; Semiglazov VF; Yue W; Edamatsu Kh; Ito Kh; Santen R
Vopr Onkol; 1999; 45(5):504-10. PubMed ID: 10629706
[TBL] [Abstract][Full Text] [Related]
19. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
[TBL] [Abstract][Full Text] [Related]
20. Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection.
Matsuzaki S; Canis M; Pouly JL; Déchelotte PJ; Mage G
Fertil Steril; 2006 Feb; 85(2):308-13. PubMed ID: 16595205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]